Showing results (371-380 of 405) with videos related to

Sort By:
Pageof 41
American Journal of Respiratory and Critical Care Medicine|November 24, 2001
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivityR T Schermuly, E Krupnik, H Tenor, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 23, 2000
Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)?N Weissmann, A Tadic, J Hänze, et al.
The European Respiratory Journal|June 8, 2010
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertensionV S Nikam, R T Schermuly, R Dumitrascu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 3, 2001
Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14U Maus, S Herold, H Muth, et al.
The European Respiratory Journal|September 29, 2006
Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumoniasP Markart, C Ruppert, M Wygrecka, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2010
Inflammation, immunological reaction and role of infection in pulmonary hypertensionS S Pullamsetti, R Savai, W Janssen, et al.
Circulation|January 5, 2000
Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generationU Sibelius, U Grandel, M Buerke, et al.
The European Respiratory Journal|June 14, 2008
Shroom expression is attenuated in pulmonary arterial hypertensionJ Sevilla-Pérez, M Königshoff, G Kwapiszewska, et al.
Thrombosis and Haemostasis|September 19, 2014
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatmentC Veith, D Zakrzewicz, B K Dahal, et al.
Circulation|January 15, 1996
Omega-3 lipid infusion in a heart allotransplant model. Shift in fatty acid and lipid mediator profiles and prolongation of transplant survivalF Grimminger, H Grimm, D Führer, et al.
Pageof 41